These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 24378974)

  • 1. The effect of recombinant human soluble thrombomodulin on disseminated intravascular coagulation in an abdominal aortic aneurysm.
    Hoshina K; Shigematsu K; Hosaka A; Okamoto H; Miyata T; Watanabe T
    Blood Coagul Fibrinolysis; 2014 Jun; 25(4):389-91. PubMed ID: 24378974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative disseminated intravascular coagulation complicated by thoracic aortic aneurysm treated using recombinant human soluble thrombomodulin: A case report.
    Tanigawa Y; Yamada Y; Nakamura K; Yamashita T; Nakagawachi A; Sakaguchi Y
    Medicine (Baltimore); 2021 Mar; 100(9):e25044. PubMed ID: 33655983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful treatment with the combination of recombinant human soluble thrombomodulin and gabexate mesilate in three patients with obstetric disseminated intravascular coagulation].
    Kumura T; Aoyama Y; Ichihara H; Koh S; Mugitani A; Hayakawa H; Yukioka K; Kinoshita D; Nakagawa M; Yamazaki N
    Rinsho Ketsueki; 2011 Feb; 52(2):68-72. PubMed ID: 21403426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
    Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
    J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent administration of recombinant human soluble thrombomodulin successfully controlled chronic disseminated intravascular coagulation in a patient with dissecting aortic aneurysm on an outpatient basis.
    Iyama S; Sato T; Murase K; Kamihara Y; Ono K; Kikuchi S; Takada K; Miyanishi K; Sato Y; Takimoto R; Kobune M; Kato J
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):548-50. PubMed ID: 22732250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activation of coagulation and fibrinolysis in patients with abdominal true aortic aneurysm associated with disseminated intravascular coagulation].
    Akaike M; Yokoi K; Wada M; Sebe T; Shigekiyo T; Kawai H; Saito S
    Kokyu To Junkan; 1993 Mar; 41(3):267-70. PubMed ID: 8469833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial.
    Saito H; Maruyama I; Shimazaki S; Yamamoto Y; Aikawa N; Ohno R; Hirayama A; Matsuda T; Asakura H; Nakashima M; Aoki N
    J Thromb Haemost; 2007 Jan; 5(1):31-41. PubMed ID: 17059423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with recombinant thrombomodulin on disseminated intravascular coagulation caused by urinary tract infections; a retrospective comparative study with control cases].
    Machioka K; Shigehara K; Kadomoto S; Iwamoto H; Miyagi T; Nakashima T; Namiki M
    Hinyokika Kiyo; 2015 Jan; 61(1):1-6. PubMed ID: 25656012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
    Yamada S; Asakura H
    Int J Hematol; 2021 Jan; 113(1):15-23. PubMed ID: 33175341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC.
    Aota T; Wada H; Yamashita Y; Matsumoto T; Ohishi K; Suzuki K; Imai H; Usui M; Isaji S; Katayama N
    Int J Hematol; 2016 Feb; 103(2):173-9. PubMed ID: 26590919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal aortic aneurysm complicated with chronic disseminated intravascular coagulopathy: a case of surgical treatment.
    Mukaiyama H; Shionoya S; Ikezawa T; Kamiya T; Hamaguchi M; Saito H
    J Vasc Surg; 1987 Dec; 6(6):600-4. PubMed ID: 3121870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of the safety and efficacy of recombinant human soluble thrombomodulin in patients with obstetrical disseminated intravascular coagulation.
    Kobayashi T; Kajiki M; Nihashi K; Honda G
    Thromb Res; 2017 Nov; 159():109-115. PubMed ID: 29153952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of recombinant human soluble thrombomodulin in the management of HELLP syndrome complicated by DIC.
    Ikezoe T; Ikenoue N; Uchikawa N; Kojima S; Fukaya T; Yokoyama A
    Thromb Res; 2010 Sep; 126(3):e238-40. PubMed ID: 20627281
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effective use of camostat mesilate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm].
    Yoneda K; Amano I; Tanaka H; Yagi H; Tsukaguchi N; Morii T; Narita N
    Rinsho Ketsueki; 2001 Jan; 42(1):30-4. PubMed ID: 11235131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two aged patients with chronic renal failure and chronic disseminated intravascular coagulation secondary to aortic aneurysms: effect of continuous subcutaneous heparin infusion therapy].
    Kurihara I; Yamaguchi Y; Soma J; Sato H; Ito S; Saito T
    Nihon Jinzo Gakkai Shi; 2000 Oct; 42(7):603-7. PubMed ID: 11155705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors.
    Ouchi K; Takahashi S; Chikamatsu S; Ito S; Takahashi Y; Kawai S; Okita A; Kasahara Y; Okada Y; Imai H; Komine K; Saijo K; Takahashi M; Shirota H; Takahashi M; Gamoh M; Ishioka C
    Int J Clin Oncol; 2018 Aug; 23(4):790-798. PubMed ID: 29511940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmarketing Surveillance of Recombinant Human Soluble Thrombomodulin (Thrombomodulin α) in Pediatric Patients With Disseminated Intravascular Coagulation.
    Shirahata A; Mimuro J; Takahashi H; Tsuji H; Kitajima I; Matsushita T; Eguchi Y; Kitamura N; Honda G; Sakata Y
    Clin Appl Thromb Hemost; 2014 Jul; 20(5):465-72. PubMed ID: 24563247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
    Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
    Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabexate as a therapy for disseminated intravascular coagulation.
    Umeki S; Adachi M; Watanabe M; Yaji S; Soejima R
    Arch Intern Med; 1988 Jun; 148(6):1409-12. PubMed ID: 3132124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective control of relapsing disseminated intravascular coagulation in a patient with decompensated liver cirrhosis by recombinant soluble thrombomodulin.
    Hasebe T; Sawada K; Nakajima S; Maeda S; Abe M; Suzuki Y; Ohtake T; Hasebe C; Fujiya M; Kohgo Y
    Intern Med; 2014; 53(1):29-33. PubMed ID: 24390524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.